Total submissions: 15
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001054658 | SCV001219004 | pathogenic | PRPH2-related disorder | 2024-11-27 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 172 of the PRPH2 protein (p.Arg172Gln). This variant is present in population databases (rs61755793, gnomAD 0.003%). This missense change has been observed in individual(s) with autosomal dominant macular dystrophy or central areolar choroidal dystrophy in families, albeit with incomplete penetrance (PMID: 8485576, 19038374, 19243827). It has also been observed to segregate with disease in related individuals. This variant is also known as RDS p.Arg172Gln. ClinVar contains an entry for this variant (Variation ID: 13167). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on PRPH2 protein function. For these reasons, this variant has been classified as Pathogenic. |
Blueprint Genetics | RCV001074392 | SCV001239970 | pathogenic | Retinal dystrophy | 2019-08-06 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000084982 | SCV001249905 | pathogenic | not provided | 2017-11-01 | criteria provided, single submitter | clinical testing | |
NEI Ophthalmic Genomics Laboratory, |
RCV001250353 | SCV001424674 | pathogenic | Patterned dystrophy of the retinal pigment epithelium | 2020-01-07 | criteria provided, single submitter | clinical testing | The variant NM_000322.4:c.515G>A in the PRPH2 gene has been previously studied(PMIDs 8485576, 22003107, 25082885, 27977834, 28559085, 29555955). We found this variant in 2 patient(s) in a PRPH2 cohort study (Reeves et al. 2020). This variant is listed in dbSNP and/or HGMD (rs61755793,CM930637). It is present in gnomAD browser (AF 0.00000406). It is enriched in the PRPH2 disease cohort. We invoked ACMG criteria [PS4, PP1-S, PM1, PM2, PP3, PP5] and classified NM_000322.4:c.515G>A in the PRPH2 gene as a Pathogenic mutation. |
NEI Ophthalmic Genomics Laboratory, |
RCV001250367 | SCV001424700 | pathogenic | Stargardt disease | 2020-01-07 | criteria provided, single submitter | clinical testing | The variant NM_000322.4:c.515G>A in the PRPH2 gene has been previously studied(PMIDs 8485576, 22003107, 25082885, 27977834, 28559085, 29555955). We found this variant in 2 patient(s) in a PRPH2 cohort study (Reeves et al. 2020). This variant is listed in dbSNP and/or HGMD (rs61755793,CM930637). It is present in gnomAD browser (AF 0.00000406). It is enriched in the PRPH2 disease cohort. We invoked ACMG criteria [PS4, PP1-S, PM1, PM2, PP3, PP5] and classified NM_000322.4:c.515G>A in the PRPH2 gene as a Pathogenic mutation. |
Institute of Medical Genetics and Applied Genomics, |
RCV000084982 | SCV001447858 | pathogenic | not provided | 2020-10-23 | criteria provided, single submitter | clinical testing | |
Institute of Human Genetics, |
RCV001799605 | SCV002044448 | pathogenic | Vitelliform macular dystrophy 3 | 2021-12-14 | criteria provided, single submitter | clinical testing | _x000D_ Criteria applied: PM5_STR, PP1_STR, PS4_MOD, PM2_SUP, PP3 |
Institute of Human Genetics, |
RCV001074392 | SCV005069765 | likely pathogenic | Retinal dystrophy | 2023-01-01 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000014053 | SCV000034300 | pathogenic | Choroidal dystrophy, central areolar 2 | 1993-03-01 | no assertion criteria provided | literature only | |
Retina International | RCV000084982 | SCV000117118 | not provided | not provided | no assertion provided | not provided | ||
Department of Clinical Genetics, |
RCV000787663 | SCV000926652 | pathogenic | Retinitis pigmentosa | 2018-04-01 | no assertion criteria provided | research | |
Department of Clinical Genetics, |
RCV000787664 | SCV000926653 | pathogenic | Macular dystrophy | 2018-04-01 | no assertion criteria provided | research | |
Leiden Open Variation Database | RCV000084982 | SCV001744961 | pathogenic | not provided | 2021-04-06 | no assertion criteria provided | curation | Curator: Global Variome, with Curator vacancy. Submitters to LOVD: LOVD, Manon Peeters. |
Clinical Genetics, |
RCV000084982 | SCV001923785 | pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000084982 | SCV001954752 | likely pathogenic | not provided | no assertion criteria provided | clinical testing |